Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALPRAZOLAM vs LORAZEPAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ALPRAZOLAM vs LORAZEPAM: Safety Overview

Metric ALPRAZOLAM LORAZEPAM
Total FAERS Reports 48,357 33,404
Deaths Reported 16,072 6,187
Death Rate 33.2% 18.5%
Hospitalizations 15,996 15,431
Average Patient Age 48.1 yrs 49.8 yrs
% Female Patients 60.4% 60.8%
FDA Approval Date Approved Prior to Jan 1, 1982 Approved Prior to Jan 1, 1982
Manufacturer Endo USA, Inc. Hikma Pharmaceuticals USA Inc.
Route ORAL INTRAMUSCULAR
Marketing Status Prescription Prescription